Endometrial carcinoma in tamoxifen-treated breast cancer patients
- PMID: 1779263
- DOI: 10.1080/1120009x.1991.11739104
Endometrial carcinoma in tamoxifen-treated breast cancer patients
Abstract
Tamoxifen is an important agent for the treatment of breast cancer. Occasionally the drug, which is an antiestrogen, has agonistic estrogenic activity. The authors describe three new cases of endometrial carcinoma developing in breast cancer patients taking tamoxifen and stress the necessity of carefully monitoring the uterine cavity under tamoxifen treatment.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical